Bellicum Pharmaceuticals, Inc. (BLCM)
Share Price Chart
The chart shows the growth of $10,000 invested in Bellicum Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $17 for a total return of roughly -99.83%. All prices are adjusted for splits and dividends.
Compare to other instruments
Bellicum Pharmaceuticals, Inc. had a return of -44.44% year-to-date (YTD) and -77.01% in the last 12 months. Over the past 10 years, Bellicum Pharmaceuticals, Inc. had an annualized return of -54.01%, while the S&P 500 had an annualized return of 8.11%, indicating that Bellicum Pharmaceuticals, Inc. did not perform as well as the benchmark.
|5 years (annualized)||-65.34%||7.32%|
|10 years (annualized)||-54.01%||8.11%|
Monthly Returns Heatmap
Bellicum Pharmaceuticals, Inc. doesn't pay dividends
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below shows the maximum drawdowns of the Bellicum Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Bellicum Pharmaceuticals, Inc. is 99.87%, recorded on Mar 17, 2023. The portfolio has not recovered from it yet.
|-99.87%||Jan 12, 2015||2060||Mar 17, 2023||—||—||—|
|-19.93%||Dec 19, 2014||3||Dec 23, 2014||7||Jan 5, 2015||10|
Current Bellicum Pharmaceuticals, Inc. volatility is 377.76%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.